EPHA2 and hepatocellular carcinoma: We verified the application value of EPHA2 by analyzing data from the TCGA database, and the results showed that EPHA2 was differentially expressed in a variety of tumors, and its high expression was associated with poor prognosis in HCC, but the difference between the high and low expression of EPHA2 was not statistically significant.